BDBM434945 ((1aR,2S,5R,5aR,6S,8aS,9R,10aR)-5,5a,6-trihydroxy-1,1,7,9-tetramethyl-11-oxo-1a,2,5,5a,6,9,10,10a-octahydro-1H-2,8a-methanocyclopenta[a]cyclopropa[e][10]annulen-4-yl)methyl (4-chlorophenyl)(methyl)carbamate::US10583140, Example 5
SMILES C[C@@H]1C[C@@H]2[C@H]([C@@H]3C=C(COC(=O)N(C)c4ccc(Cl)cc4)[C@@H](O)[C@]4(O)[C@@H](O)C(C)=C[C@@]14C3=O)C2(C)C
InChI Key InChIKey=RDRXJIFSIDDRJA-WQSXYEEUSA-N
Data 1 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 434945
TargetGag-Pol polyprotein(Human immunodeficiency virus type 1 (HIV-1))
Glaxosmithkline Intellectual Property Development
US Patent
Glaxosmithkline Intellectual Property Development
US Patent
Affinity DataEC50: 616nMAssay Description:For the Jurkat HIV Latency assay, compounds are dissolved and titrated in DMSO and diluted 100-fold in assay medium (RPMI-1640 containing 10% fetal b...More data for this Ligand-Target Pair